Edrecolomab (Monoclonal Antibody 17-1A)

This publication has 31 references indexed in Scilit:

• Prevention of manifest metastasis with monoclonal antibodies: A novel approach to immunotherapy of solid tumours
  European Journal Of Cancer, 1995
• Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
  The Lancet, 1994
• Effect of monoclonal antibody 17‐1A and gm‐CSF in patients with advanced colorectal carcinoma—long‐lasting, complete remissions can be induced
  International Journal of Cancer, 1993
• Phase II Multicenter Evaluation of Prolonged Murine Monoclonal Antibody 17-1A Therapy in Pancreatic Carcinoma
  Journal of Immunotherapy, 1993
• Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
  The Lancet, 1992
• Induction of Anti-Idiotypic (ab₂) and Anti-Anti-Idiotypic (ab₃) Antibodies in Patients Treated with the Mouse Monoclonal Antibody 17-1A (ab₁). Relation to the Clinical Outcome — An Important Antitumoral Effector Function?
  Hybridoma, 1991
• A phase II trial of murine monoclonal antibody 17-1A and interferon-γ: Clinical and immunological data
  Cancer Immunology, Immunotherapy, 1990
• The epithelial cell surface antigen 17–1A, a target for antibody‐mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies
  International Journal of Cancer, 1986
• Binding of murine immunoglobulin to human tissues after immunotherapy with anticolorectal carcinoma monoclonal antibody
  International Journal of Cancer, 1984
• Human Macrophages Armed with Murine Immunoglobulin G2a Antibodies to Tumors Destroy Human Cancer Cells
  Science, 1983